drugset / Trial / NCT05131867

Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy

NCT05131867

Phase 2 Completed 30 enrolled Zagazig University
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of oral Nimodipine and IV milrinone combination therapy for management of cerebral spasm after aneurysmal subarachnoid hemorrhage.

Timeline

Start
2021-11-24
Primary completion
2022-05-23
Completion
2022-05-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milrinone Small molecule 0.75 ug/kg Intravenous
Comparator Nimodipine Small molecule 60 mg Oral